If you follow the standard titration, one 10 mg vial provides: Phase 1 (weeks 1 to 4 at 0.25 mg): uses 1 mg Phase 2 (weeks 5 to 8 at 0.5 mg): uses 2 mg Phase 3 (weeks 9 to 12 at 1.0 mg): uses 4 mg Total through 12 weeks: 7 mg used, 3 mg remaining Remaining 3 mg covers about 1.5 to 2 more weeks at 1.7 mg One vial
Reuss DE, Habel A, Hagenlocher C, Mucha J, Ackermann U, Tessmer C, Meyer J, Capper D, Moldenhauer G, Mautner V, Frappart PO
Eli Lilly's GLP-1 drug Zepbound is poised to "dominate" the weight loss market, according to a recent note from BMO
A few months later, it said the shortage for the other one, semaglutide, that was over as well
The transition period from high glucose to stable metabolic health Many patients entering treatment have lived with insulin resistance or elevated glucose for years